0001484612-24-000018.txt : 20240117
0001484612-24-000018.hdr.sgml : 20240117
20240117200312
ACCESSION NUMBER: 0001484612-24-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240112
FILED AS OF DATE: 20240117
DATE AS OF CHANGE: 20240117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Racine Jean-Olivier
CENTRAL INDEX KEY: 0001868039
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39513
FILM NUMBER: 24539830
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outset Medical, Inc.
CENTRAL INDEX KEY: 0001484612
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 200514392
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 669-231-8200
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
FORMER COMPANY:
FORMER CONFORMED NAME: Home Dialysis Plus, Ltd.
DATE OF NAME CHANGE: 20100219
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2024-01-12
0
0001484612
Outset Medical, Inc.
OM
0001868039
Racine Jean-Olivier
3052 ORCHARD DRIVE
SAN JOSE
CA
95134
0
1
0
0
Chief Technology Officer
0
Common Stock
2024-01-12
4
A
0
96000
0.0
A
169781
D
Common Stock
2024-01-12
4
A
0
100000
0.0
A
269781
D
Common Stock
2024-01-12
4
A
0
4638
0.0
A
274419
D
Common Stock
2024-01-16
4
S
0
723
4.29
D
273696
D
Represents restricted stock units ("RSU") granted to the reporting person on January 12, 2024. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 12, 2025, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.
Represents performance-based restricted stock units ("PSUs") granted to the reporting person on January 12, 2024, that vest over a three year period based on the Issuer's common stock achieving specified prices per share, if not earlier vested upon satisfaction of specified performance criteria, subject to the reporting person's continuous service through the applicable vesting date. Each PSU represents a contingent right to receive one share of common stock.
On January 26, 2022, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2023. The reported amount represents the number of PSUs earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive one share of common stock. These PSUs vested 50% on January 12, 2024, and the remaining 50% shall vest on December 31, 2024, subject to the reporting person's continuous service through the vesting date.
Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs on January 12, 2024 described in footnote (3) above. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
By: John L Brottem For: Jean-Olivier Racine
2024-01-17